Detalles de la búsqueda
1.
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.
Ann Rheum Dis
; 83(6): 706-719, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38499325
2.
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.
Rheumatology (Oxford)
; 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38218744
3.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357155
4.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953263
5.
Efficacy of secukinumab on dactylitis in patients with active psoriatic arthritis from the FUTURE 5 study.
Clin Exp Rheumatol
; 41(3): 589-596, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35916290
6.
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Adult patients.
Australas J Dermatol
; 64(4): 476-487, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501636
7.
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Mod Rheumatol
; 33(4): 668-679, 2023 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920102
8.
Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials.
Ann Rheum Dis
; 81(2): 206-213, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34615638
9.
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis.
Rheumatology (Oxford)
; 61(8): 3257-3268, 2022 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864911
10.
Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study.
Clin Exp Rheumatol
; 40(5): 952-959, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34494957
11.
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms.
Curr Rheumatol Rep
; 24(10): 310-320, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861937
12.
Differentiation of renal masses with multi-parametric MRI: the de Silva St George classification scheme.
BMC Urol
; 22(1): 141, 2022 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057604
13.
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Mod Rheumatol
; 32(2): 263-272, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910188
14.
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.
Lancet
; 395(10235): 1496-1505, 2020 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32386593
15.
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Ann Rheum Dis
; 80(7): 848-858, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504485
16.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Ann Rheum Dis
; 80(1): 71-87, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158881
17.
Clinical use of Jak 1 inhibitors for rheumatoid arthritis.
Rheumatology (Oxford)
; 60(Suppl 2): ii31-ii38, 2021 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33950231
18.
The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers.
BMC Urol
; 21(1): 67, 2021 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33888122
19.
Secukinumab Efficacy in Psoriatic Arthritis: Machine Learning and Meta-analysis of Four Phase 3 Trials.
J Clin Rheumatol
; 27(6): 239-247, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015257
20.
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52.
Ann Rheum Dis
; 79(10): 1310-1319, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660977